StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Lonza Group AG
Swiss Stock Exchange:LONN.SW
Sector
Location
Market Cap
USD 49.69 B
Share Price
USD 707.50
Avg Daily Volume
150,788
Change (1 day)
-0.05%
Change (1 year)
22.20%
Change (YTD)
19.42%
Lonza Group AG EBITDA for the year ending December 31, 2024: USD 1.70 B
Lonza Group AG EBITDA is USD 1.70 B for the year ending December 31, 2024, a -6.69% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Lonza Group AG EBITDA for the year ending December 31, 2023 was USD 1.82 B, a -20.44% change year over year.
-
Lonza Group AG EBITDA for the year ending December 31, 2022 was USD 2.29 B, a 50.99% change year over year.
-
Lonza Group AG EBITDA for the year ending December 31, 2021 was USD 1.51 B, a -3.25% change year over year.
-
Lonza Group AG EBITDA for the year ending December 31, 2020 was USD 1.57 B, a 12.76% change year over year.
Competitors
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.98
600276.SS
+0.04
0.52%
Takeda Pharmaceutical Company Limited
USD 29.87
4502.T
+0.36
1.22%
Ucb S.A.
USD 201.26
UCB.BR
+1.45
0.73%
BeOne Medicines Ltd.
USD 252.14
ONC
+1.84
0.73%
Hansoh Pharmaceutical Group Company Limited
USD 4.19
3692.HK
+0.04
0.96%
Insmed Incorporated
USD 101.89
INSM
+3.71
3.78%
Summit Therapeutics Inc.
USD 25.40
SMMT
+0.40
1.60%
Torrent Pharmaceuticals Limited
USD 39.36
TORNTPHARM.NS
-0.23
-0.58%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.98
600276.SS
+0.04
0.52%
Takeda Pharmaceutical Company Limited
USD 29.87
4502.T
+0.36
1.22%
Ucb S.A.
USD 201.26
UCB.BR
+1.45
0.73%
BeOne Medicines Ltd.
USD 252.14
ONC
+1.84
0.73%
Hansoh Pharmaceutical Group Company Limited
USD 4.19
3692.HK
+0.04
0.96%
Insmed Incorporated
USD 101.89
INSM
+3.71
3.78%
Summit Therapeutics Inc.
USD 25.40
SMMT
+0.40
1.60%
Torrent Pharmaceuticals Limited
USD 39.36
TORNTPHARM.NS
-0.23
-0.58%